Overview

Efficacy and Safety of Aripiprazole in Patients With Schizophrenia or Bipolar Disorder

Status:
Completed
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
This is a multicenter,open-label,prospective study of Aripiprazole use in patients with schizophrenia and bipolar disorder.
Details
Lead Sponsor:
Korea Otsuka Pharmaceutical Co., Ltd.
Treatments:
Aripiprazole